ADC Capacity Updates

1. AGC Biologics Capacity Update April 2025: ADC 4/21/2025

   This presentation offers a global overview of our comprehensive ADC program, providing developers with full end-to-end support — all under a single, streamlined contract.

2. Simtra Biopharma Solutions Capacity Update April 2025: ADC 4/21/2025

   Witness how proven expertise and expanding capabilities in ADC manufacturing can help you scale high-value injectable therapies with speed, quality, and regulatory confidence.

3. Abzena Capacity Update April 2025: ADC 4/21/2025

   Our integrated expertise can help you develop and manufacture dual payload ADCs with optimized efficacy, precision conjugation, and scalable solutions.

4. Aragen Bioscience, Inc. Capacity Update April 2025: ADC 4/21/2025

   Discover how our end-to-end ADC solutions — from advanced conjugation technologies to scalable manufacturing — can accelerate your therapeutic development.

5. Simtra BioPharma Solutions Capacity Update October 2024: ADC 10/21/2024

   We've expanded our U.S. and Germany sites to offer end-to-end services for product development, clinical and commercial fill/finish, and ADC conjugation and purification by 2025.

6. Mycenax Capacity Update October 2024: ADC 10/21/2024

   Partner with us for full-service ADC development and production, from feasibility to GMP manufacturing, with industry-leading standards and flexible capacities.

7. KBI Biologics Capacity Update October 2024: ADC 10/21/2024

   This presentation underscores the essential role of comprehensive characterization in ensuring that ADCs not only meet regulatory standards but also achieve therapeutic goals.

8. JOINN Biologics Capacity Update October 2024: ADC 10/21/2024

   Leverage our flexible solutions and access to proprietary CHO-K1 cell lines in our state-of-the-art cGMP suites equipped with both single-use and traditional stainless steel bioreactors to support your complex biologics needs.

9. Catalent Capacity Update October 2024: ADC 10/21/2024

   Advance ADC development with the SMARTag® Platform, combining precision bioconjugation and a linker-payload library to enhance the therapeutic index and accelerate timelines.

10. AGC Biologics Capacity Update October 2024: ADC 10/21/2024

    Streamline your ADC project with the Proveo alliance, offering seamless, end-to-end support across antibody production, bioconjugation, and aseptic fill.